Some posters have commented on the difficulty in getting surgeons to change products and habits and the various reasons for that and also the huge task that our sales people face in getting CardioCel accepted as the premier solution. The following is an extract from a report on claims against Cardiovascular Systems Inc. which probably reinforces the views of some posters that incentives are offered to surgeons to use a particular product -
"The FCA suit, filed in 2013 and unsealed 2 years later, accuses CSI of inducing physicians to use its products by offering free, all-expense-paid training programs “followed by explicit demands by CSI employees that attendees use CSI products on future patients,” giving away product for free, 3rd-party referral channel marketing, and “sham Speaker Bureau payments for high-prescribers and others whom CSI sought to cultivate,” according to the complaint filed in the U.S. District Court for Western North Carolina."
Attached is a link to the full article -
http://www.massdevice.com/sharehold...systems-wins-extension-settle-kickbacks-case/
- Forums
- ASX - By Stock
- AVR
- Reasons to keep holding Admedus shares
Reasons to keep holding Admedus shares, page-34
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M |
Open | High | Low | Value | Volume |
$15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 297 | $15.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.25 | 1300 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 297 | 15.000 |
1 | 60 | 14.800 |
1 | 67 | 14.750 |
1 | 25 | 14.640 |
1 | 206 | 14.500 |
Price($) | Vol. | No. |
---|---|---|
15.250 | 1300 | 2 |
15.400 | 238 | 1 |
15.500 | 370 | 1 |
15.660 | 1925 | 2 |
15.850 | 554 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online